Stifel lowered the firm’s price target on Amdocs (DOX) to $97 from $100 and keeps a Buy rating on the shares following an earnings report the firm views as “decidedly mixed.” The FY26 outlook was lower than expected, notes the firm, which is lowering its own estimates.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOX:
- Amdocs price target lowered to $97 from $100 at BofA
- Amdocs: Buy Rating Affirmed Amid Strong Backlog, Cloud Growth, and AI Opportunities
- Amdocs Reports Fiscal 2025 Earnings and Strategic Outlook
- Amdocs expands managed services agreement with Globe
- Amdocs signs pact with Vivo to modernize operations support systems